256 related articles for article (PubMed ID: 31733122)
21. Nongenital herpes simplex virus.
Usatine RP; Tinitigan R
Am Fam Physician; 2010 Nov; 82(9):1075-82. PubMed ID: 21121552
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
[TBL] [Abstract][Full Text] [Related]
23. Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107
Khan AA; Srivastava R; Vahed H; Roy S; Walia SS; Kim GJ; Fouladi MA; Yamada T; Ly VT; Lam C; Lou A; Nguyen V; Boldbaatar U; Geertsema R; Fraser NW; BenMohamed L
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899087
[TBL] [Abstract][Full Text] [Related]
24. Recrudescent herpes simplex infection mimicking primary herpetic gingivostomatitis.
Christie SN; McCaughey C; Marley JJ; Coyle PV; Scott DA; Lamey PJ
J Oral Pathol Med; 1998 Jan; 27(1):8-10. PubMed ID: 9466728
[TBL] [Abstract][Full Text] [Related]
25. T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?
Posavad CM; Wald A; Hosken N; Huang ML; Koelle DM; Ashley RL; Corey L
J Immunol; 2003 Apr; 170(8):4380-8. PubMed ID: 12682275
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures.
Miller CS; Cunningham LL; Lindroth JE; Avdiushko SA
J Am Dent Assoc; 2004 Sep; 135(9):1311-8. PubMed ID: 15493396
[TBL] [Abstract][Full Text] [Related]
27. A nurse practitioner's guide to the management of herpes simplex virus-1 in children.
Drugge JM; Allen PJ
Pediatr Nurs; 2008; 34(4):310-8. PubMed ID: 18814565
[TBL] [Abstract][Full Text] [Related]
28. Herpes simplex infection--Part II: Management of HSV infections.
Yarom N; Buchner A; Dayan D
Refuat Hapeh Vehashinayim (1993); 2006 Apr; 23(2):6-13, 65. PubMed ID: 16886871
[TBL] [Abstract][Full Text] [Related]
29. Dok-1 and Dok-2 Are Required To Maintain Herpes Simplex Virus 1-Specific CD8
Lahmidi S; Yousefi M; Dridi S; Duplay P; Pearson A
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490594
[TBL] [Abstract][Full Text] [Related]
30. Oral acyclovir (Zovirax) in the treatment of recurrent herpetic gingivostomatitis and recurrent herpes labialis.
Quong TL
Hawaii Dent J; 1989 Oct; 20(10):10, 12, 14 passim. PubMed ID: 2630545
[No Abstract] [Full Text] [Related]
31. Diagnosis and management of recurrent herpes simplex infections.
Siegel MA
J Am Dent Assoc; 2002 Sep; 133(9):1245-9. PubMed ID: 12356256
[TBL] [Abstract][Full Text] [Related]
32. Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure.
Parker ZM; Pasieka TJ; Parker GA; Leib DA
J Virol; 2016 Dec; 90(23):10789-10799. PubMed ID: 27681121
[TBL] [Abstract][Full Text] [Related]
33. Adeno-associated Virus Vectors Efficiently Transduce Mouse and Rabbit Sensory Neurons Coinfected with Herpes Simplex Virus 1 following Peripheral Inoculation.
Watson ZL; Ertel MK; Lewin AS; Tuli SS; Schultz GS; Neumann DM; Bloom DC
J Virol; 2016 Sep; 90(17):7894-901. PubMed ID: 27334582
[TBL] [Abstract][Full Text] [Related]
34. Saliva enhances infection of gingival fibroblasts by herpes simplex virus 1.
Zuo Y; Whitbeck JC; Haila GJ; Hakim AA; Rothlauf PW; Eisenberg RJ; Cohen GH; Krummenacher C
PLoS One; 2019; 14(10):e0223299. PubMed ID: 31581238
[TBL] [Abstract][Full Text] [Related]
35. An update on short-course intermittent and prevention therapies for herpes labialis.
Gilbert S; Corey L; Cunningham A; Malkin JE; Stanberry L; Whitley R; Spruance S
Herpes; 2007 Jun; 14 Suppl 1():13A-18A. PubMed ID: 17877887
[TBL] [Abstract][Full Text] [Related]
36. Treatment of mucocutaneous presentations of herpes simplex virus infections.
Nikkels AF; Pièrard GE
Am J Clin Dermatol; 2002; 3(7):475-87. PubMed ID: 12180895
[TBL] [Abstract][Full Text] [Related]
37. The natural history of primary herpes simplex type 1 gingivostomatitis in children.
Amir J; Harel L; Smetana Z; Varsano I
Pediatr Dermatol; 1999; 16(4):259-63. PubMed ID: 10469407
[TBL] [Abstract][Full Text] [Related]
38. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy.
Pepose JS; Keadle TL; Morrison LA
Am J Ophthalmol; 2006 Mar; 141(3):547-557. PubMed ID: 16490506
[TBL] [Abstract][Full Text] [Related]
39. Herpes. Vaccines for HSV.
Stanberry LR
Dermatol Clin; 1998 Oct; 16(4):811-6, xiv. PubMed ID: 9891686
[TBL] [Abstract][Full Text] [Related]
40. Herpes Simplex Virus 1 Reactivates from Autonomic Ciliary Ganglia Independently from Sensory Trigeminal Ganglia To Cause Recurrent Ocular Disease.
Lee S; Ives AM; Bertke AS
J Virol; 2015 Aug; 89(16):8383-91. PubMed ID: 26041294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
